Tag: post-approval regulatory requirements

Manufacturing Changes and Generic Approval: What Triggers FDA Re-evaluation

Discover what manufacturing changes trigger FDA re-evaluation for generic drugs. Learn about PAS, CBE, and AR categories, costs, and strategies to minimize delays.

read more